Bringing together researchers, regulators, industry representatives, healthcare professionals, and patient-focused organisations from around the world, the 42nd International Society for Pharmacoepidemiology (ISPE) Annual Meeting provided a unique opportunity to exchange knowledge and discuss the future of pharmacoepidemiology and Real-World Evidence...

WP2 is where regulatory science meets real-world practice. Co-Led by the University of Oxford, University of Edinburgh and Bayer, this work package engages regulators and stakeholders to co-create evidence-based best practice recommendations as well as tools for using Real-World Data...

The GREG Consortium together for the first General Assembly (GA) in Copenhagen, Denmark - May 2026 Welcome back to the GREG Newsletter! Having reached the first anniversary of project launch, we’d like to give you an update on progress, achievements...

Led by NICE (UK) and co-led by Medtronic, WP3 collaborates with Health Technology Assessment (HTA) bodies, payers, and industry to bridge the gap between Real-World Data (RWD) and its application in HTA, improving decision-making for medicines, medical devices, and drug-device...

WP1 is the foundation of GREG, leading the co-creation of evidence-based practical guidance for the use of real-world data (RWD) and real-world evidence (RWE) in regulatory and health technology assessment (HTA) decision-making. Led by the Aragonese Institute of Health Sciences...

The IHI-GREG project is excited to present a session at the upcoming in-person Patient Engagement Open Forum (PEOF), focusing on Real-World Data (RWD) and Real-World Evidence (RWE). This interactive workshop-style session will explore how to bridge knowledge gaps, build capacity...

Last week GREG held its annual Consortium Meeting in Copenhagen on 6–7th May 2026, bringing together partners from across the project to review progress, align on next steps, and strengthen collaboration. The meeting opened with an overview of achievements to...

At the beginning of this week, GREG returned to Rotterdam for another international meeting, this time presenting at the OHDSI Europe Symposium 2026.  This event brings together global leaders in health data science, Real-World Evidence (RWE), and open-source collaboration. It was an excellent opportunity...

Daniel Prieto-Alhambra (Erasmus MC), Tara Srouji (Novo Nordisk), and Annika Jödicke (University of Oxford) GREG’s Project Coordinator, Daniel Prieto-Alhambra, and Academic Co-Lead Annika Jödicke, took the stage at DIA Europe 2026 to present the project’s groundbreaking approach to real-world evidence...

The meeting included 14 HTA experts that assess Real-World Evidence (RWE) submissions, generate national RWE to inform local pricing and reimbursement decisions, or work at a policy level to support RWE developments in HTA. These experts from across Europe and...

As coordinators of the GREG project, we are thrilled to share the first edition of the GREG Newsletter with you. These newsletters will be published bi-annually and provide regular updates including progress of the project, achievements and upcoming events. In...

The GREG Consortium has taken part in the European Society of Cardiology (ESC) annual Congress, held in Madrid from August 29 to September 1, 2025. This event continues to be a cornerstone in the global cardiology calendar, bringing together thought...

The GREG project officially commenced with a two-day Kick-Off Meeting held in Rotterdam on 14–15 May, where around 80 participants from academia, industry, regulatory bodies, and patient organisations took part. Supported by the Innovative Health Initiative (IHI JU), GREG aims...

The GREG project has been officially launched to address persistent challenges in the generation, implementation, and acceptance of Real-World Evidence (RWE) for medicines, medical devices, and drug-device combinations in Europe. The GREG Initiative Will Tackle Persistent Challenges in Real-World Evidence...